BACKGROUND: Chinese injection drug users (IDUs) may be a proper candidate population for HIV vaccine trials. OBJECTIVE: To evaluate willingness to participate (WTP) in HIV vaccine trials among Chinese IDUs. METHODS: Questionnaire interviews were completed among 401 IDUs in Urumqi City in northwestern China in 2005. RESULTS: Overall 74.3% of participants said that they would be definitely willing to participate in HIV vaccine trials, 17.7% were probably willing, 6.2% were probably not willing, and remaining 1.8% were definitely not willing to join. Multivariate logistic regression analysis demonstrated that WTP was positively associated with having ever had sex with a drug use partner (adjusted odds ratio [AOR]: 1.8; 95% confidence interval [CI]: 1.04, 3.2), sharing needle and syringe with a new drug use partner in the past 3 months (AOR: 3.8; 95% CI: 1.2, 11.7), perceived family support for participation (AOR: 7.4; 95% CI: 4.3, 12.7), and perceived vaccine protection against HIV infection (AOR: 16.1; 95% CI: 3.7, 70.8), and was negatively associated with perceived risk of social stigma and isolation for participation (AOR: 0.3; 95% CI: 0.2, 0.5). CONCLUSIONS: The stated WTP in hypothetical HIV vaccine trials was high among Chinese IDUs. Further studies are needed to evaluate actual enrollment into the trials.
BACKGROUND: Chinese injection drug users (IDUs) may be a proper candidate population for HIV vaccine trials. OBJECTIVE: To evaluate willingness to participate (WTP) in HIV vaccine trials among Chinese IDUs. METHODS: Questionnaire interviews were completed among 401 IDUs in Urumqi City in northwestern China in 2005. RESULTS: Overall 74.3% of participants said that they would be definitely willing to participate in HIV vaccine trials, 17.7% were probably willing, 6.2% were probably not willing, and remaining 1.8% were definitely not willing to join. Multivariate logistic regression analysis demonstrated that WTP was positively associated with having ever had sex with a drug use partner (adjusted odds ratio [AOR]: 1.8; 95% confidence interval [CI]: 1.04, 3.2), sharing needle and syringe with a new drug use partner in the past 3 months (AOR: 3.8; 95% CI: 1.2, 11.7), perceived family support for participation (AOR: 7.4; 95% CI: 4.3, 12.7), and perceived vaccine protection against HIV infection (AOR: 16.1; 95% CI: 3.7, 70.8), and was negatively associated with perceived risk of social stigma and isolation for participation (AOR: 0.3; 95% CI: 0.2, 0.5). CONCLUSIONS: The stated WTP in hypothetical HIV vaccine trials was high among Chinese IDUs. Further studies are needed to evaluate actual enrollment into the trials.
Authors: K M MacQueen; S Vanichseni; D Kitayaporn; L S Lin; A Buavirat; T Naiwatanakul; S Raktham; P Mock; W L Heyward; D C Des Jarlais; K Choopanya; T D Mastro Journal: J Acquir Immune Defic Syndr Date: 1999-07-01 Impact factor: 3.731
Authors: Elizabeth T Golub; Lisa A Purvis; Marcella Sapun; Mahboobeh Safaeian; Chris Beyrer; David Vlahov; Steffanie A Strathdee Journal: AIDS Behav Date: 2005-09
Authors: S Piyasirisilp; F E McCutchan; J K Carr; E Sanders-Buell; W Liu; J Chen; R Wagner; H Wolf; Y Shao; S Lai; C Beyrer; X F Yu Journal: J Virol Date: 2000-12 Impact factor: 5.103
Authors: Edith A M Tarimo; Anna Thorson; Thecla W Kohi; Joachim Mwami; Muhammad Bakari; Eric Sandström; Asli Kulane Journal: BMC Public Health Date: 2010-05-28 Impact factor: 3.295
Authors: E A M Tarimo; M Bakari; D C V Kakoko; T W Kohi; F Mhalu; E Sandstrom; A Kulane Journal: BMC Public Health Date: 2016-02-24 Impact factor: 3.295